Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Opin Ther Pat. 2012 Mar;22(3):341-8. doi: 10.1517/13543776.2012.665877. Epub 2012 Feb 25.

Hybrid nanocrystals: University of Kentucky US20060280680A1.

Author information

1
University of Illinois, Department of Biopharmaceutical Sciences, Chicago, IL 60612-7231, USA.

Abstract

This patent application claims an interesting and novel combination of passive accumulation of drug nanocrystals within diseased tissue, in combination with active uptake of the nanocrystals by diseased cells. The patent application further claims the hybrid nanocrystals combining imaging or stabilizing molecules as inclusions in the crystal matrix. There is a focus on cancer chemotherapy and imaging, but the initial claims are not disease specific. In this patent evaluation, the novelty and utility of this application is examined, while the state of the art in nanocrystal formulations and formulation is discussed.

PMID:
22364361
PMCID:
PMC3742739
DOI:
10.1517/13543776.2012.665877
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center